Salarius Pharmaceuticals ... (SLRX)
NASDAQ: SLRX
· Real-Time Price · USD
0.79
0.02 (2.46%)
At close: May 12, 2025, 3:57 PM
Salarius Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| Grant, Castration-Resistant Prostate Study Revenue | 2.6M |
| Grant, Castration-Resistant Prostate Study Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.31M | 869.24K | 1.25M | 1.53M | 910.75K | 1.5M | 1.62M | 1.7M | 1.79M | 1.83M | 1.84M | 1.68M | 1.45M | 1.73M | 1.59M | 1.33M | 1.21M | 1.33M | 1.7M | 1.86M | 1.76M | 3.49M | 1.5M | 2.3M | 1.92M | 1.96M | 2.99M | 3.7M | 3.98M | 4.93M | 4.99M | 4.59M | 3.92M | 5.45M | 5.38M | 5.11M | 4.62M | 4.72M | 3.9M | 3.22M |
| Selling, General, and Administrative Revenue Growth | +51.09% | -30.63% | -18.03% | +67.84% | -39.11% | -7.64% | -4.46% | -5.42% | -2.17% | -0.24% | +9.46% | +15.77% | -16.27% | +8.72% | +19.44% | +9.89% | -9.02% | -21.63% | -8.50% | +5.58% | -49.61% | +133.35% | -34.88% | +19.68% | -1.96% | -34.55% | -19.00% | -7.18% | -19.29% | -1.12% | +8.62% | +17.25% | -28.07% | +1.30% | +5.21% | +10.61% | -2.14% | +20.95% | +21.40% | n/a |
| Research and Development Revenue | 175.34K | 137.23K | 214.45K | 243K | 59.95K | 1.04M | 2.35M | 3.73M | 4.69M | 3.79M | 2.92M | 4.44M | 2.7M | 2.02M | 2.1M | 1.74M | 2.02M | 1.8M | 1.44M | 1.64M | 1.34M | 1.14M | 29.29K | 1.71K | 187.76K | 865.76K | 6.17M | 4.68M | 4.26M | 4.74M | 4.08M | 3.91M | 4.23M | 5.67M | 6.09M | 4.39M | 3.31M | 3.45M | 3.19M | 2.8M |
| Research and Development Revenue Growth | +27.77% | -36.01% | -11.75% | +305.32% | -94.22% | -55.93% | -36.87% | -20.49% | +23.63% | +29.73% | -34.19% | +64.69% | +33.72% | -3.83% | +20.43% | -13.98% | +12.19% | +24.97% | -12.17% | +22.83% | +17.27% | +3794.68% | +1617.12% | -99.09% | -78.31% | -85.98% | +31.93% | +9.88% | -10.13% | +16.27% | +4.12% | -7.47% | -25.32% | -7.05% | +38.93% | +32.58% | -3.95% | +7.99% | +13.73% | n/a |